# Effect of Antiseizure Medication on the Salience Network in Patients with Epilepsy with Generalized Tonic-Clonic Seizures Alone

**Authors:** Cătălina Elena Bistriceanu, Georgiana-Anca Vulpoi, Iulian Stoleriu, Dan Iulian Cuciureanu

PMC · DOI: 10.3390/biomedicines12071521 · Biomedicines · 2024-07-09

## TL;DR

This study explores how antiseizure medications affect brain regions involved in attention and awareness in epilepsy patients.

## Contribution

The study reveals how specific antiseizure drugs influence the salience network in epilepsy patients.

## Key findings

- Patients treated with valproic acid and carbamazepine showed marked differences in salience network regions compared to controls.
- Patients treated with levetiracetam showed few differences in brain regions compared to controls.
- Untreated patients showed no significant differences in salience network regions compared to controls.

## Abstract

This study aimed to investigate the effects of antiepileptic drugs on salience network regions in patients with epilepsy with generalized tonic-clonic seizures alone (EGTCSa). A retrospective observational case-control study was performed on 40 patients diagnosed with epilepsy with EGTCSa and 40 healthy age-matched controls. In LORETA, a voxel-by-voxel analysis between regions from the salience network was performed for both hemispheres, specifically between the anterior cingulate (BA 32 and BA 24) and the sublobar insula (BA 13). Subsequently, a Wilcoxon rank-sum test (the Mann-Whitney U test) was conducted for the equality of medians in the transformation matrix. A comparison was then made between each region of interest as defined by the salience network and the controls. Marked differences were found in the brain regions assessed in patients with EGTCSa treated with valproic acid and carbamazepine compared to the control group; few differences in patients treated with levetiracetam; and no difference was found in the group without treatment compared with those in the control group. These results suggest that ASMs can influence cognitive processes, which provide novel insights toward understanding the neural mechanisms underlying the effects of ASMs administration.

## Linked entities

- **Chemicals:** valproic acid (PubChem CID 3121), carbamazepine (PubChem CID 2554), levetiracetam (PubChem CID 5284583)
- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Diseases:** Tonic-Clonic Seizures (MESH:D012640), Epilepsy (MESH:D004827)
- **Chemicals:** valproic acid (MESH:D014635), carbamazepine (MESH:D002220), levetiracetam (MESH:D000077287), Antiseizure Medication (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11275025/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11275025/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC11275025/full.md

---
Source: https://tomesphere.com/paper/PMC11275025